iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology

iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology

Progress made during the last decade in stem cell biology allows currently an unprecedented potential to translate these advances into the clinical applications and to shape the future of regenerative medicine. Organoid technology is amongst these major developments, derived from primary tissues or...

Full description

Bibliographic Details
Main Authors: Ali G. Turhan, Jinwook W. Hwang, Diana Chaker, Albert Tasteyre, Theodoros Latsis, Frank Griscelli, Christophe Desterke, Annelise Bennaceur-Griscelli
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Medicine
Subjects:
induced pluripotent stem (IPS) cell
organoid
cancer
drug discovery
regenerative medicine
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.728543/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.728543/full

Similar Items